Clene (NASDAQ:CLNN) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.15) by 66.67 percent. The company reported quarterly sales of $201.00 thousand which beat the analyst consensus estimate of $60.00 thousand by 235.00 percent.
Clene Q2 EPS $(0.05) Beats $(0.15) Estimate, Sales $201.00K Beat $60.00K Estimate
Clene (NASDAQ:CLNN) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.15) by 66.67 percent. The company reported quarterly sales of $201.00 thousand which beat the analyst
